*Created on 2023-11-06, 18:05* 

---
- A humanized antibody against CD20 used to treat chronic lymphocytic leukemia and relapsing-remitting multiple sclerosis.
- Ocrelizumab and ofatumumab have a common mechanism of action; however, they bind different epitopes on the CD20 molecule. Ofatumumab is also a fully human antibody, whereas ocrelizumab is a humanized antibody. 